Bladder cancer
UPDATED --- New hope for patients progressing after prior treatment for mUCaPeggy (75 years old)
Peggy, 75 years old, used to be a history teacher. Since her retirement, she has kept her passion alive by helping to organise the historical reenactment of the Battle of Waterloo.
Unfortunately, she was diagnosed with high-grade urothelial MIBC T2N0M0 and underwent neoadjuvant gemcitabine + cisplatin followed by radical chemoradiotherapy. 3 months later, a CT scan revealed multiple retroperitoneal lymph nodes and lung metastases. She started pembrolizumab 7 months ago. 12 weeks after the start of pembrolizumab, a CT scan showed marginal progression in the lymph node metastases, but she continued with the immunotherapy. She presents again today.
Assessment summary:
- ECOG PS: 2
- Haemoglobin: 11.5 g/dl
- Peripheral neuropathy: grade 1 due to prior cisplatin
- Grade 2 immunotherapy-related hypothyroidism, treated with hormone replacement therapy
- No hearing impairment
- GFR: 45 ml/min
- CT scan reveals new and enlarging lymph node lesions
- FGFR2/3 alteration status in metastatic biopsy specimen: activating FGFR3 mutation